[Chronic lymphoid leukemia and intravenous immunoglobulins]

MeSH terms

• Agammaglobulinemia / complications
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / therapeutic use
• Drug Therapy, Combination
• Evidence-Based Medicine
• Female
• Humans
• Immunoglobulins, Intravenous / administration & dosage
• Immunoglobulins, Intravenous / therapeutic use*
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / therapeutic use
• Infections / complications
• Leukemia, Lymphocytic, Chronic, B-Cell / complications
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
• Leukemia, Lymphocytic, Chronic, B-Cell / immunology
• Leukemia, Lymphocytic, Chronic, B-Cell / mortality
• Male
• Multicenter Studies as Topic
• Prognosis
• Prospective Studies
• Randomized Controlled Trials as Topic
• Remission Induction
• Time Factors
• Treatment Outcome
• Vidarabine / administration & dosage
• Vidarabine / analogs & derivatives
• Vidarabine / therapeutic use